Crescendo Bioscience
South San Francisco
About Crescendo Bioscience
Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $141.7M
- Funding stage: M&A
- Last round: Series D (Jan 2013)
- Website: crescendobio.com
- Phone: (800) 469-7423
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/crescendo-bioscience-2441089 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.